EXECUTIVE ENGAGEMENTS
OUTREACH
903
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
181
Interactions with Platform & by Email
PARTICIPANTS
36
Unique # Participated
VALIDATIONS
16
Responses Validated*
COMPETITORS
34
Responses Validated*
BRANDS
0
Responses Validated*
* Login for a full stack data experience
DATE
FEB 2021
TABLES
150
PAGES
214
EDITION
6
PRICE
USD $5600
HIGHLIGHTS
Amid the COVID-19 crisis, the global market for Protein Sequencing estimated at US$957.8 Million in the year 2020, is projected to reach a revised size of US$1.2 Billion by 2027, growing at aCAGR of 3.1% over the period 2020-2027. Mass Spectrometry, one of the segments analyzed in the report, is projected to record 2.9% CAGR and reach US$757.3 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Edman Degradation segment is readjusted to a revised 3.4% CAGR for the next 7-year period.
The Protein Sequencing market in the U.S. is estimated at US$281.5 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$211.7 Million by the year 2027 trailing a CAGR of 3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.9% and 2.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.1% CAGR.We bring years of research experience to this 6th edition of our report. The 130-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
SELECT PLAYERS
Agilent Technologies; Bioinformatics Solution; Charles River Laboratories; Proteome Factory; Rapid Novor; Selvita; SGS (SA); Shimadzu Corp.; Thermo Fischer Inc.; Water Corporation
SEGMENTS
» Technology (Mass Spectrometry, Edman Degradation) » Application (Biotherapeutics, Genetic Engineering, Other Applications) » End-Use (Academic Institutes & Research Centers, Pharma & Biotech Companies, Other End-Uses)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| Impact of Covid-19 and a Looming Global Recession |
| Global Competitor Market Shares |
| Protein Sequencing Competitor Market Share Scenario Worldwide (in %): 2020E |
| Global Competitor Market Shares by Segment |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for Protein Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Protein Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Protein Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Mass Spectrometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Mass Spectrometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Mass Spectrometry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Edman Degradation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Edman Degradation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Edman Degradation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Biotherapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Biotherapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Biotherapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Genetic Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Genetic Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Genetic Engineering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Academic Institutes & Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Academic Institutes & Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Academic Institutes & Research Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| Market Facts & Figures |
| USA Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2012, 2020 & 2027 |
| USA Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2012, 2020 & 2027 |
| USA Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2012, 2020 & 2027 |
| CANADA |
| Canada Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2012, 2020 & 2027 |
| Canada Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2012, 2020 & 2027 |
| Canada Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2012, 2020 & 2027 |
| JAPAN |
| Japan Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2012, 2020 & 2027 |
| Japan Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2012, 2020 & 2027 |
| Japan Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2012, 2020 & 2027 |
| CHINA |
| China Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2012, 2020 & 2027 |
| China Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2012, 2020 & 2027 |
| China Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2012, 2020 & 2027 |
| EUROPE |
| Market Facts & Figures |
| Europe Current & Future Analysis for Protein Sequencing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Protein Sequencing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Protein Sequencing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2012, 2020 & 2027 |
| FRANCE |
| France Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2012, 2020 & 2027 |
| France Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2012, 2020 & 2027 |
| France Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2012, 2020 & 2027 |
| GERMANY |
| Germany Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2012, 2020 & 2027 |
| Germany Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2012, 2020 & 2027 |
| Germany Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2012, 2020 & 2027 |
| ITALY |
| Italy Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2012, 2020 & 2027 |
| Italy Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2012, 2020 & 2027 |
| Italy Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2012, 2020 & 2027 |
| UNITED KINGDOM |
| UK Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2012, 2020 & 2027 |
| UK Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2012, 2020 & 2027 |
| UK Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2012, 2020 & 2027 |
| REST OF EUROPE |
| Rest of Europe Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2012, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2012, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2012, 2020 & 2027 |
| ASIA-PACIFIC |
| Asia-Pacific Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2012, 2020 & 2027 |
| REST OF WORLD |
| Rest of World Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2012, 2020 & 2027 |
| Rest of World Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2012, 2020 & 2027 |
| Rest of World Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2012, 2020 & 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 34 |
